Frontal stimulation to modulate threat sensitivity in anxious depression
Frontal stimulation to modulate threat sensitivity in anxious depression
批准号:
10390276
负责人:
Maria Ironside
金额:
$28.9万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2023-06-30
关键词:
AcuteAmygdaloid structureAnti-Anxiety AgentsAntidepressive AgentsAnxietyAnxiety DisordersBehavioralBehavioral MechanismsBrain regionClinicalClinical TreatmentClinical TrialsCognitiveDataDoseElectrophysiology (science)EmotionalExhibitsFaceFunctional Magnetic Resonance ImagingFunctional disorderFutureHyperactivityInterventionLearningMajor Depressive DisorderMeasuresMedicineMental DepressionMental HealthMental disordersModelingMoodsNeurosciencesPatient-Focused OutcomesPatientsPharmaceutical PreparationsPrediction of Response to TherapyPublic HealthRandomizedRelapseRestSignal TransductionStartle ReactionTestinganxiety symptomsanxiousapproach avoidance behaviorattentional controlbasecognitive neurosciencecomorbid depressioncortico-limbic circuitsdesigneffective therapyfollow-upfrontal lobehealth assessmentimaging studyimprovedinsightneural circuitneuromechanismnovelpredicting responserelating to nervous systemresponseresponse biomarkertargeted treatmenttherapy resistantvolunteer
中文摘要
超过50%的重度抑郁症(MDD)患者对最初的治疗没有反应,并且会复发
英文摘要
Over 50% of patients with major depressive disorder (MDD) do not respond to initial treatment and relapse is
common [1]. In particular, comorbid depression and anxiety disorders are associated with more treatment
resistance [2]. Thus, there is a great need for novel, more targeted treatments. Transcranial direct current
stimulation (tDCS) is a novel intervention that can be used to causally target neural excitability and plasticity in
brain regions/circuits implicated in regulating mood and anxiety and emerging evidence suggests that it reduces
threat sensitivity. Here we propose to use tDCS to target threat sensitivity as a core symptom of anxious
depression to determine if we can engage the neural circuits that are treatment targets. Following the
administration of a single dose of anxiolytic or antidepressant treatment, early changes in emotional processing
have been observed in healthy people and clinical groups. Among patients, acute cognitive effects – such as a
reduction in threat sensitivity – have been shown to predict response to drug [3] and behavioral [4] treatments.
Functional magnetic resonance imaging (fMRI) studies have confirmed hyperactive amygdala and/or hypoactive
prefrontal activity in patients, indicating an imbalance of activity within this cortico-limbic circuit that sub-serves
threat identification (amygdala) and top-down control (prefrontal). Specifically, treatments aiming to remediate
prefrontal/ amygdala dysfunction could be a critical target in patients exhibiting these deficits. Several clinical
trials have shown that administration of frontal cortex tDCS is a potentially effective treatment for MDD [5].
However, underlying mechanisms of action are unclear. To meet this gap, we propose an experimental medicine
study (target identification and initial target engagement paths) where 120 volunteers with anxious MDD will be
randomized to receive a single session of active or sham tDCS in a parallel design. Threat sensitivity will be
measured using task and resting state fMRI and potentiated startle electrophysiology. Preliminary data suggest
reductions in behavioral threat sensitivity from a single session of frontal tDCS [6]. This was followed up with an
fMRI study which found that a single session of active vs sham frontal tDCS reduced amygdala response to
fearful faces whilst simultaneously increasing frontal attentional control signals [7]. This provides evidence that
modulating activity in the frontal cortex inhibits amygdala response to threat, highlighting a potential neural
mechanism for the behavioral reduction in threat sensitivity. In addition, this offers initial mechanistic insights into
the efficacy of tDCS in clinical trials for the treatment of MDD and anxiety disorders, suggesting that threat
sensitivity may be a suitable cognitive target. The current proposal builds on this to establish acute effects of
frontal tDCS on amygdala response to threat (primary aim), frontoparietal response to threat (secondary aim),
startle response under threat (secondary aim), approach-avoidance-conflict (exploratory aim) and model-based
learning (exploratory aim). The ultimate aim is to apply these multi-level acute findings to mechanistic clinical
trials of tDCS, to test their prediction of treatment response (full model path) and improve patient outcomes
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Processes and circuitry underlying threat sensitivity as a treatment target for comorbid anxiety and depression
-
批准号:10625215
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2023
-
负责人:Maria Ironside
-
依托单位:
Frontal stimulation to modulate threat sensitivity in anxious depression
-
批准号:10377706
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2021
-
负责人:Maria Ironside
-
依托单位: